Legal Representation
Attorney
Ronald A. DiCerbo
USPTO Deadlines
Next Deadline
1947 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250520)
Due Date
May 20, 2031
Grace Period Ends
November 20, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
38 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 20, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| May 20, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 29, 2025 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Apr 29, 2025 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Feb 20, 2025 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Dec 10, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Feb 21, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Dec 10, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Jun 25, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 30, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 30, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 10, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 26, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 26, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Mar 26, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 26, 2024 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 26, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Nov 9, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 8, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 8, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 23, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 23, 2023 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 23, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 23, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 22, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 22, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 30, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 30, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jun 30, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 30, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jun 30, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| May 22, 2023 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| May 22, 2023 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Feb 22, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 22, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 22, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 3, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 23, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Detailed Classifications
Class 042
Genetic and genomic testing services in the field of cancer, for scientific research purposes; molecular profiling of tumors for scientific research purposes; genetic and genomic testing, namely sequencing and profiling services for scientific research purposes; genetic and genomic analysis services for scientific research purposes; providing temporary use of online non-downloadable software for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations; DNA screening and analysis services; genomic and genetic testing services relating to drug development and clinical trials for scientific research purposes; providing temporary use of online non-downloadable software being genetic and genomic sequencing technology in the fields of cancer, genetics, and genomics
First Use Anywhere:
20220400
First Use in Commerce:
20220400
Class 044
Genetic and genomic testing services in the field of cancer, for medical purposes; medical testing in the nature of molecular profiling of tumors for diagnostic or treatment purposes; genetic and genomic testing, namely sequencing and profiling services for medical purposes; genetic and genomic medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical testing in the nature of DNA screening and analysis for diagnostic or treatment purposes; genomic and genetic testing services relating to drug development and clinical trials for medical purposes
First Use Anywhere:
20220400
First Use in Commerce:
20220400
Classification
International Classes
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"ARRAY"